+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Brain Tumor Therapeutics Market 2019-2023 - Product Image

Global Brain Tumor Therapeutics Market 2019-2023

  • ID: 4772989
  • Report
  • Region: Global
  • 126 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Novartis AG
  • MORE
The rising prevalence of brain cancer is one of the key factors that will trigger the growth of the market. Most brain tumors are identified only in the late stages. The delay in diagnosis leads to the tumor becoming malignant. Also, factors such as cancer becoming metastasis are associated with the increasing prevalence of brain cancer. Therefore, the morbid nature of the disease, increasing mortality rate and the huge unmet need caused by the rising prevalence of this disease is expected to increase the use of therapeutics for the treatment. Thus, such factors are expected to drive the growth of the market during the forecast period. Analysts have predicted that the brain tumor therapeutics market will register a CAGR of almost 12% by 2023.

Market Overview

Strategic alliances

The market is expected to witness an increase in the number of strategic alliances between the universities and vendors, during the forecast period, thus adding significant growth to the global brain tumor therapeutics market.

Preference for substitutes

The ease of treatment is expected to increase the demand for the alternating electric field therapy. This is expected to be a major challenge for the growth of the global brain tumor therapeutics market during the forecast period.

Competitive Landscape

The market appears to be concentrated and with the presence of few companies including Bristol-Myers Squibb Co., and Eisai Co. Ltd., the competitive environment is quite intense. Several organizations are focusing on launching various products such as grey armbands, grey rings, and grey ribbon pins to promote the severity and awareness of brain cancer. The rising number of awareness campaigns is expected to result in the early diagnosis of the disease, thereby driving the market growth. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Novartis AG
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Small molecules - Market size and forecast 2018-2023
  • Biologics - Market size and forecast 2018-2023
  • Market opportunity by type
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Novartis AG
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 16: EXPLORE

List of Exhibits:
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market characteristics analysis
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Global brain tumor therapeutics market pipeline: Overview
Exhibit 19: Global brain tumor therapeutics market pipeline: Snapshot
Exhibit 20: Type - Market share 2018-2023 (%)
Exhibit 21: Comparison by type
Exhibit 22: Small molecules - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Small molecules - Year-over-year growth 2019-2023 (%)
Exhibit 24: Biologics - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Biologics - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Customer landscape analysis
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: North America - Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in North America
Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Europe
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in Asia
Exhibit 40: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 42: Top 3 countries in ROW
Exhibit 43: Key leading countries
Exhibit 44: Market opportunity
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendor landscape analysis
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 53: Bristol-Myers Squibb Co. - Business segments
Exhibit 54: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 55: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 56: Bristol-Myers Squibb Co. - Key offerings
Exhibit 57: Bristol-Myers Squibb Co. - Key customers
Exhibit 58: Eisai Co. Ltd. - Vendor overview
Exhibit 59: Eisai Co. Ltd. - Business segments
Exhibit 60: Eisai Co. Ltd. - Organizational developments
Exhibit 61: Eisai Co. Ltd. - Geographic focus
Exhibit 62: Eisai Co. Ltd. - Segment focus
Exhibit 63: Eisai Co. Ltd. - Key offerings
Exhibit 64: Eisai Co. Ltd. - Key customers
Exhibit 65: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 66: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 67: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 68: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 69: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 70: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 71: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 72: Merck & Co. Inc. - Vendor overview
Exhibit 73: Merck & Co. Inc. - Business segments
Exhibit 74: Merck & Co. Inc. - Organizational developments
Exhibit 75: Merck & Co. Inc. - Geographic focus
Exhibit 76: Merck & Co. Inc. - Segment focus
Exhibit 77: Merck & Co. Inc. - Key offerings
Exhibit 78: Merck & Co. Inc. - Key customers
Exhibit 79: Novartis AG - Vendor overview
Exhibit 80: Novartis AG - Business segments
Exhibit 81: Novartis AG - Organizational developments
Exhibit 82: Novartis AG - Geographic focus
Exhibit 83: Novartis AG - Segment focus
Exhibit 84: Novartis AG - Key offerings
Exhibit 85: Novartis AG - Key customers
Exhibit 86: Validation techniques employed for market sizing
Exhibit 87: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Novartis AG
  • MORE
The analyst recognizes the following companies as the key players in the global brain tumor therapeutics market: Bristol-Myers Squibb Co., Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., and Novartis AG.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the increasing special drug designations.”

According to the report, one of the major drivers for this market is the high morbidity of brain tumors.

Further, the report states that one of the major factors hindering the growth of this market is the trail failures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Novartis AG
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4772989
Adroll
adroll